Clasado Biosciences will present new research on Bimuno GOS at the International Sport & Exercise Nutrition Conference (ISENC) 2025.
The research, conducted at Nottingham Trent University, has been accepted for presentation at ISENC 2025 and examines the effects of prebiotic Bimuno GOS supplementation in elite and highly trained female team sport players.
The conference is one of Europe's leading sport and exercise nutrition events and takes place from 15th to 17th December, at Manchester Metropolitan University Business School.
ISENC brings together the world's leading experts and attracts delegates in the highest roles in nutrition from around the world, representing major sports teams, brands and educational institutions.
Samantha Abbott, doctoral researcher at Nottingham Trent University's Sport, Health and Performance Enhancement (SHAPE) Research Centre, will present findings from an eight-week randomised, double-blind, placebo-controlled study involving 27 female athletes during a competitive winter season.
The research explored the effects of Bimuno GOS on multiple aspects of athlete health and wellbeing, with particular focus on gastrointestinal health, immune function and sleep quality.
These are the three critical factors that influence training consistency and athletic performance.
Dr Georgina Dodd, Senior Scientist & Clinical Project Manager at Clasado, commented: "Being selected to present at ISENC, Europe's premier sport and exercise nutrition conference, is a significant recognition of the quality and relevance of this research."
"This latest study represents an important step in understanding how prebiotics can support female athletes specifically, demonstrating statistically significant outcomes across several key health markers that directly impact an athlete's ability to train and compete consistently."
"We're particularly pleased to see promising findings related to sleep quality, which complement preliminary observations from previous research."
The study found favourable, statistically significant improvements in upper respiratory symptom duration, symptom-free days and a marker of mucosal immune function in the Bimuno GOS group compared to placebo.
Athletes also reported improved sleep quality following supplementation with Bimuno GOS.
This latest research highlights how Bimuno GOS addresses multiple pathways, of which it is evident that supporting gut health can ultimately contribute to better athlete health and wellbeing.
Steven Riley, Head of Marketing at Clasado, added: "Prebiotics are increasingly recognised as a valuable tool in the sports nutrition formulator's arsenal."
"By supporting gut health, immune function and overall wellbeing, Bimuno GOS enables sports nutrition brands to differentiate their products through clinically substantiated benefits that address real challenges athletes face."
This research follows a recent study examining Bimuno GOS and gut health in male athletes under heat stress conditions, further strengthening the ingredient's evidence base in sports nutrition applications.
Full details of the new female athlete study are anticipated to be published in 2026.